Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage.
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of stroke, with delayed
cerebral ischemia (DCI) as a major complication. There are several evidences, both in
preclinical and in clinical studies that intraventricular fibrinolysis (IVF) controls the
phenomenon that are leading to DCI. Here, the investigators propose to conduct a phase III
trial to provide a clear evaluation of the impact of IVF after aneurysmal SAH.